Here's What Two Dietitians Have To Say About Poppi And Other Prebiotic Sodas So You Can Make Your Own Informed Decision

20 May 2025 Agreement’s adoption follows three years of intensive negotiation launched due to gaps and inequities identified in national and global COVID-19 response. Agreement boosts global collabo

Riyadh, Kingdom of Saudi Arabia – 19 May 2025 – The WHO Foundation has signed a strategic Memorandum of Understanding (MoU) with Tawuniya, Saudi Arabia’s largest insurance provider, marking its

15 May 2025, Cairo, Egypt – The World Health Organization (WHO) Regional Office for the Eastern Mediterranean has launched a landmark innovation designed to transform how countries prepare for and

13 May 2025 Thank you for joining today’s WHO/EMRO press briefing. I always appreciate the opportunity to connect with our media colleagues. I will begin with an update on some of the most acute eme

12 May 2025 – Cairo/Geneva/Jerusalem, The risk of famine in Gaza is increasing with the deliberate withholding of humanitarian aid, including food, in the ongoing blockade. The entire 2.1 million po

12 May 2025, Rabat, Morocco – World Health Organization (WHO) Regional Director for the Eastern Mediterranean Dr Hanan Balkhy concluded her first official visit to Morocco, from 5 to 7 May 2025. Th

12 May 2025, Cairo, Egypt – On International Nurses Day 2025, celebrated on 12 May, the World Health Organization (WHO) Regional Office for the Eastern Mediterranean and United Arab Emirates are hos

12 May 2025, Cairo, Egypt – The eighth UN Global Road Safety Week begins on 12 May. This year, the international campaign, requested by the United Nations General Assembly, focuses on walking and cy

12 May 2025 Good morning, and a very warm welcome to all of you. As we commemorate International Nurses Day, we honour the dedication, resilience, and leadership of nurses across the Eastern Mediterra

Scientists in the U.K., Australia and China have identified a brain molecule called NEAT1 that appears to play a central role in triggering light sensitivity (photophobia), a common and debilitating symptom of migraines. Their findings, published in The Journal of Headache and Pain, highlight how this molecule affects the brain's pain response, contributing to the uncomfortable reaction to light that's common during migraines.

For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.

Use of extracorporeal membrane oxygenation (ECMO) continues to rise, but this advanced form of life support is often not provided to patients equitably. Now, new research published at the ATS 2025 International Conference has confirmed that disadvantaged patients are less likely to receive ECMO, even though they live closer to hospitals that offer it.

Older adults requiring long-term care frequently experience multiple disabilities, with considerable variation in the combinations of these impairments. Because of this diversity, interventions that focus on a single impairment may not be sufficient. Therefore, understanding the complex physical and cognitive conditions of older adults in need of care is essential for developing appropriate interventions.

A new study led by Profs. Xu Tao and He Shunmin from the Institute of Biophysics of the Chinese Academy of Sciences has revealed how human leukocyte antigen (HLA) genes, central to the immune system, influence both pathogen resistance and susceptibility to autoimmune diseases.

Many grooves and dimples on the surface of the brain are unique to humans, but they're often dismissed as an uninteresting consequence of packing an unusually large brain into a too-small skull.

Researchers from the University of Missouri School of Medicine have shed light on which populations are more likely to be prescribed a high dose of opioid medication. This increases their risk of developing opioid use disorder.

A study led by a physician-scientist at the University of Arizona College of Medicine–Tucson's Sarver Heart Center identified a drug candidate that appears to reverse the progression of a type of heart failure in mouse models, which could lead to expanded treatment options for humans. The results are published in the journal Cell Metabolism.